Matsudo, Japan, and Puteaux, France April 12, 2013 - Precision System Science, Co., Ltd. (PSS) and the ELITech Group (ELITech) announced they have agreed to a Joint Development, Distribution and Supply Agreement in which ELITech's ELITe MGB Real -Time PCR technology will be optimized and implemented as human in vitro diagnostic tests on the "geneLEAD" system, a fully automated Real-Time PCR analyzer developed by PSS.
PSS has profound experience in automated DNA extraction as represented by its patented Magtration technology. Using this foundation in the molecular diagnostics field, PSS has extended its leadership position with the development of fully automated, sample-to-result Real-Time PCR analyzers. By combining their own technology with PCR and multi-fluorescence assay detection technology, PSS has successfully developed simplified, small footprint and yet high performance automated Real-Time PCR analyzers. Utilizing proven strength in molecular testing consumables, PSS has also developed an efficient straight-line prefilled cartridge for extraction and PCR reagents.
The geneLEAD system has broad applicability in DNA and RNA diagnostic testing such as infectious disease, oncology, and human genetic testing. According to the agreement, geneLEAD will be used for human in vitro diagnostic tests and it well matches the wide portfolio of diagnostic reagents provided by ELITech.
ELITech has a broad array of proven PCR assays currently in use across the world for in vitro diagnostic analysis on open systems. These assays take advantage of ELITech's intellectual property portfolio which includes the Minor Groove Binder (MGB), modified bases, and novel fluorophores. The panel of assays cover a broad spectrum of tests for infectious disease, oncology and human genetics applications.
Pierre Debiais, CEO ELITech commented "The combination of PSS unique expertise in systems development, in particular in Molecular Diagnostics, and ELITech's unique IP portfolio and broad range of assays will deliver a timely attractive molecular platform".
"The process of molecular diagnostic testing is complex and customer's needs are widely diverse. The right instrument, the right reagents as well as experience with these products in the field are indispensable to be successful and meet customer expectations. The agreement between PSS and ELITech provides a novel business model that delivers unique solutions for molecular diagnostics testing" said Hideji Tajima, President PSS.
About Precision System Science, Co., Ltd (PSS)
PSS, located at Matsudo, Japan, is a leading global provider of laboratory instruments for nucleic acid extraction. The company specializes in the development and production of automated instruments. As an original equipment manufacturer, PSS is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded as a maintenance and service company for clinical laboratory instruments in 1985, the company has manufacturing, research and development sites in Japan and maintains sales and service networks in the US and Europe. Registered shares of PSS are traded on the JASDAQ under ticker code 7707.
For more information contact Precision System Science (firstname.lastname@example.org) or visit our website: www.pss.co.jp.
About the ELITech Group
The ELITech Group is a privately held group of worldwide manufacturers and distributors of in vitro diagnostic equipment and reagents. By bringing together IVD specialty companies that offer innovative products and solutions, ELITech Group has become a major contributor in advancing clinical diagnostics to laboratories in the proximity market, those operating closer to the patient. The ELITech Group manufactures and distributes diagnostic products for clinical chemistry, microbiology, immunology, and molecular biology though direct sales and a distribution network encompassing more than 100 countries.